UPDATE: Raymond James Downgrades Bed Bath & Beyond (BBBY) to Underperform

Go back to UPDATE: Raymond James Downgrades Bed Bath & Beyond (BBBY) to Underperform

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ampio, Lottery.com, NIO, and Bed Bath & Beyond and Encourages Investors to Contact the Firm

August 31, 2022 9:00 PM EDT

NEW YORK, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ampio Pharmaceuticals, Inc. (NYSEAmerican: AMPE), Lottery.com, Inc. (NASDAQ: LTRY, LTRYW), NIO, Inc. (NYSE: NIO), and Bed Bath & Beyond, Inc. (NASDAQ: BBBY). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Ampio Pharmaceuticals, Inc. (NYSEAmerican: AMPE)

... More

Bed Bath & Beyond Inc. Announces Strategic Changes to Strengthen its Financial Positioning, Drive Growth and Better Serve Customers

August 31, 2022 7:30 AM EDT

UNION, N.J., Aug. 31, 2022 /PRNewswire/ -- Bed Bath & Beyond Inc. (NASDAQ: BBBY) today announced a strategic and business update focused on changes intended to meet the demand of its customers, drive growth and profitability, and improve its balance sheet and cash flows.

Sue Gove, Director & Interim Chief Executive Officer commented, "We are embracing a straight-forward, back-to-basics philosophy that focuses on better serving our customers, driving growth, and delivering business returns.  In a short period of time, we have made... More